The SWIXIT Dilemma for Medtech – Part I

by | Apr 26, 2021 | Brexit, EU, Medical Devices

Now that the world is done dealing with the Brexit drama, there is more on the plate for the EU Commission.

The EU Commission has a Mutual Recognition Agreement with the Switzerland Parliament to allow for Swiss-approved medical devices to be placed on the European market. This agreement allows for Switzerland to take over the EU system of compliance assessment and certification which is the EU Medical Device Directives.1

Now that we are just days away from the EU Medical Device Regulations implementation date, the industry stakeholders that manufacture their products in Switzerland and that have parts of their supply chain in Switzerland are concerned about their future operations. The Mutual Recognition Agreement between the EU and the Swiss needs to be updated to include the new EU MDR and because of the current political tension between the two countries, no agreement has been reached yet.

As a result of this, to regulate medical devices, Switzerland will become a third country on the date of application of the EU MDR. This means that Swiss manufacturers will have to set up an EU authorized representative and have their CE mark transferred to an EU Notified Body. Also each time an EU law is updated, Switzerland will be left out and fall within the third country category.2

There is no doubt that if an agreement is not reached in time, this will cause disruption for Swiss medical device manufacturers and they will have to make special arrangements to stabilize their EU distribution and supply chain channels. Whether this arrangement will be temporary or permanent, and what the new Swiss Medtech transition plan looks like for medical device industry stakeholders, will be discussed in part II of this blog.

Whatever the changes are, rest assured that EMMA International is here to assist you with all your compliance needs, call us today at 248-987-4497 or email us at info@emmainternational.com to learn more.


1Swissmedic(2019) Regulation of medical devices retrieved on 04/24/2021 from https://www.swissmedic.ch/swissmedic/en/home/medical-devices/regulation-of-medical-devices.html

2Bristows (2020) MDR postponement staves off Swixit – for now retrieved on 04/24/2021 from https://www.bristows.com/news/mdr-postponement-staves-off-swixit-for-now/

Nikita Angane

Nikita Angane

Solutions Delivery Specialist - Ms. Angane is a Bioengineering graduate with experience in medical device commercialization, product development, quality system compliance and regulatory affairs. Her portfolio includes working on medical devices, combination products, and pharmaceuticals. As a Solutions Delivery Specialist at EMMA International, she offers her expertise to help our clients achieve an effective and sustainable quality system, and develop regulatory strategies for market access and compliance of new products in the US and international markets. Ms. Angane earned a Bachelor of Engineering in Biomedical Engineering from the University of Mumbai, India and an M.S. in Bioengineering from University of Illinois at Chicago.

More Resources

Pattern Recognition as a Quality Superpower

Pattern Recognition as a Quality Superpower

There are always new ways and reasons to apply pattern recognition to quality improvement. Better ensuring patient outcomes in health care facilities and improving accuracy for medical diagnoses are two such frontiers.
Record Control for a Regulated World

Record Control for a Regulated World

In a regulated industry, the prevailing posture of regulatory representatives, in my experience, has been “Show me proof.” In fact, the philosophy I’ve heard repeated by regulators is “If it wasn’t documented, it didn’t happen.”
EU MDR SSCP’s: The Importance of Readability

EU MDR SSCP’s: The Importance of Readability

Among many of the new requirements that EU MDR has introduced, the Summary of Safety and Clinical Performance (SSCP) is certainly one of the more confusing ones for many firms. SSCP’s are required for implantable and Class III devices under EU MDR and is intended to be a public document summarizing important safety and clinical performance information about the device.

Ready to learn more about working with us?

Pin It on Pinterest

Share This